Skip to main content

Table 3 Cox regression analysis for survival

From: Low ERCC1 expression is a good predictive marker in lung adenocarcinoma patients receiving chemotherapy based on platinum in all TNM stages - a single-center study

  

HR

95% CI

p

Sex

Male

0.803

0.594–1.086

0.154

Age (years)

≤65

1.063

0.797–1.417

0.678

Smoking status

Yes

1.110

0.573–2.153

0.757

ECOG

0–4

1.684

1.450–1.956

< 0.001

Tumor size

T1

  

< 0.001

T2

1.336

0.649–2.750

T3

2.214

1.089–4.501

T4

4.445

2.212–8.935

Lymph node

Positive

4.132

2.660–6.418

< 0.001

Metastasis

Yes

3.498

2.391–5.118

< 0.001

TNM stagea

I + II

  

< 0.001

III

2.488

1.265–4.891

IV

5.474

3.107–9.645

ERCC1

≤ 0.1

6.478

4.035–10.401

< 0.001

> 0.1

  1. aTNM stage was grouped as (I + II): III: IV